Directors & Officers

As of April 1, 2022

OutsideOutside Director

IndependentIndependent officer pursuant to Article 436-2 of the regulations of Tokyo Stock Exchange, Inc.

Directors

Photo:Dr. Osamu Okuda Dr. Osamu OkudaRepresentative Director, President & CEO
Supervisory responsibility for Corporate Planning, Partnering, External Affairs and Audit
In charge of Corporate Planning Dept., External Affairs Dept., and Audit Dept.

Date of Birth    April 5, 1963

  • 1987 Joined the Company
  • 2008 Department Manager of Lifecycle Management Dept. II
  • 2009 Department Manager and Lifecycle Leader of Lifecycle Management Dept. II
  • 2011 President of Roche Products (Ireland) Limited
  • 2013 Head of Oncology Unit, Marketing & Sales Div. of the Company
  • 2014 Executive Officer, Head of Oncology Unit,
    Marketing & Sales Div. of the Company
  • 2015 Executive Officer, Head of Corporate Planning Dept. of the Company
  • 2017 Executive Vice President, Head of Corporate Planning Dept. of the Company
  • 2018 Executive Vice President, Co-Head of Project & Lifecycle Management Unit
  • 2020 Representative Director and President (to present)
    COO
  • 2021 CEO (to present)
Photo:Dr. Hisafumi Yamada Dr. Hisafumi YamadaDirector, Executive Vice President
Supervisory responsibility for Project & Lifecycle Management (R&D), Research, Translational Research, Clinical Development and Pharmaceutical Technology

Date of Birth    July 12, 1957

  • 1991 Joined Nippon Roche K.K.
  • 2002 Department Manager of Pharmaceutical Research Dept. IV
  • 2007 Director, Forerunner Pharma Research Co., Ltd.
  • 2009 Vice President and General Manager of Research Div.
    Head, C&C Research Laboratories (Korea)
  • 2012 Director and COO, Chugai Pharmabody Research Pte. Ltd. (Singapore)
  • 2016 Senior Vice President and General Manager of Research Div.
  • 2018 Executive Vice President and Head of Translational Research Div.
  • 2018 Executive Vice President (to present)
  • 2022 Director (to present)
Photo:Toshiaki Itagaki Toshiaki ItagakiDirector, Executive Vice President & CFO
Supervisory responsibility for Finance & Accounting, Corporate Communication and Purchasing
Head of Finance Supervisory Div.

Date of Birth    November 23, 1960.

  • 1983 Joined the Company
  • 2007 General Manager of Finance & Accounting Dept.
  • 2010 Department Manager of Planning & Research Dept.
  • 2012 Department Manager of Marketing & Sales Planning Dept.
  • 2015 Vice President, General Manager of Finance & Accounting Dept.
  • 2018 Executive Vice President & CFO (to present)
    Head of Finance Supervisory Div. (to present)
    Head of IT Supervisory Div. and Head of Finance & Accounting Dept.
  • 2022 Director (to present)
Photo:Masayuki Oku OutsideIndependent Masayuki Oku Outside Director of Rengo Co., Ltd.
Outside Director of The Royal Hotel, Ltd.
Outside Director of TV TOKYO Holdings Corporation
Non-Executive Director of The Bank of East Asia

Date of Birth    December 2, 1944

  • 1968 Joined The Sumitomo Bank, Ltd. (“SB”)
  • 1994 Director of SB
  • 1998 Managing Director of SB
  • 1999 Managing Director and Managing Executive Officer of SB
  • 2001 Senior Managing Director and Senior Managing Executive Officer of SB
    Senior Managing Director and Senior Managing Executive Officer of Sumitomo Mitsui Banking Corporation (“SMBC”)
  • 2002 Senior Managing Director of Sumitomo Mitsui Financial Group, Inc. (“SMFG”)
  • 2003 Deputy President and Executive Officer of SMBC
  • 2005 Chairman of SMFG
    President and Chief Executive Officer of SMBC
  • 2008 Outside Director of Panasonic Corporation
    Outside Director of Nankai Electric Railway Co., Ltd.
  • 2009 Director of Nikko Cordial Securities Inc.
  • 2014 Outside Director of Kao Corporation.
    Outside Director of Komatsu Ltd.
  • 2015 Director of the Company (to present)
    Non-Executive Director of The Bank of East Asia (to present)
  • 2017 Director of SMFG
    Honorary Advisor of SMFG (to present)
  • 2019 Outside Director of Rengo Co., Ltd. (to present)
    Outside Director of The Royal Hotel, Ltd. (to present)
  • 2021 Outside Director of TV TOKYO Holdings Corporation (to present)
Photo:Yoichiro Ichimaru OutsideIndependent Yoichiro Ichimaru Outside Director of Seino Holdings Co., Ltd.

Date of Birth    October 10, 1948

  • 1971 Joined Toyota Motor Sales Co., Ltd.
  • 2001 Member of the Board of Directors of Toyota Motor Corporation (“TMC”)
  • 2003 Managing Executive Officer of TMC
  • 2005 Senior Managing Director of TMC
  • 2009 Representative Director, Executive Vice President of TMC
    Corporate Auditor of Aioi Insurance Co., Ltd.
  • 2010 Corporate Auditor of Aioi Nissay Dowa Insurance Co., Ltd.
  • 2011 Senior Corporate Auditor of TMC
  • 2015 Executive Advisor of TMC
    Representative Director, Chairman of Aioi Nissay Dowa Insurance Co., Ltd.
  • 2017 Director of the Company (to present)
    Senior Advisor of Aioi Nissay Dowa Insurance Co., Ltd.
  • 2019 Outside Director of Seino Holdings Co., Ltd. (to present)
Photo:Dr. Mariko Momoi OutsideIndependent Dr. Mariko Y Momoi Professor Emeritus of Jichi Medical University
Visiting Professor of School of Medicine, Shinshu University
Regent of Tokyo Medical University (part-time)

Date of Birth    February 24, 1948

  • 1994 Head of Department of Pediatrics, Jichi Medical University
  • 2006 Director of Jichi Children’s Medical Center Tochigi
  • 2010 Dean of School of Medicine, Jichi Medical University
  • 2012 Visiting Professor of School of Medicine, Shinshu University (to present)
  • 2013 Professor Emeritus of Jichi Medical University (to present)
    Vice President of International University of Health and Welfare
  • 2014 Director of Japanese Medical Specialty Board (part-time)
  • 2015 Vice President of International University of Health and Welfare and Head of IUHW Hospital
  • 2017 Chief Medical Officer of Ryoumou Seishi Ryogoen, Kiryu Ryoiku Futabakai Social Welfare Corporation
  • 2018 Regent of Tokyo Medical University (part-time) (to present)
  • 2020 Director of the Company (to present)
Photo:Dr. Christoph Franz Dr. Christoph Franz Chairman of the Board of Directors of Roche Holding Ltd.
Vice-Chairman of the Board of Directors of Zurich Insurance Group Ltd. (Switzerland)
Member of the Board of Directors of Stadler Rail Ltd. (Switzerland)

Date of Birth    May 2, 1960

  • 1990 Joined Deutsche Lufthansa AG
  • 1994 Member of the Executive Board and CEO of Passenger Transport Division of Deutsche Bahn AG
  • 2004 CEO of Swiss International Air Lines AG
  • 2009 Deputy Chairman of the Executive Board of Deutsche Lufthansa AG
  • 2011 Chairman of the Executive Board and CEO of Deutsche Lufthansa AG
  • 2014 Chairman of the Board of Directors of Roche Holding Ltd. (to present)
  • 2017 Director of the Company (to present)
Photo:William N. Anderson William N. Anderson CEO of Roche Pharmaceuticals and Member of the Roche Corporate Executive Committee

Date of Birth    August 23, 1966

  • 1997 Joined Biogen Idec
  • 1999 Managing Director, United Kingdom and Ireland of Biogen Idec
  • 2001 Vice President of Finance, Business Planning of Biogen Idec
  • 2004 Vice President and General Manager of Neurology Business Unit of Biogen Idec
  • 2006 Senior Vice President of Immunology & Ophthalmology Business Unit of Genentech
  • 2010 Senior Vice President of BioOncology Business Unit of Genentech
  • 2013 Head of Global Product Strategy, Chief Marketing Officer of Roche
  • 2017 CEO of Genentech
  • 2019 CEO of Roche Pharmaceuticals and Member of the Roche Corporate Executive Committee (to present)
    Director of the Company (to present)
Photo:Dr. James H. Sabry Dr. James H. Sabry Global Head of Roche Pharma Partnering and Member of the Roche
Enlarged Corporate Executive Committee

Date of Birth    December 19, 1958

  • 1997 Co-founder, President and CEO of Cytokinetics
  • 2008 President and CEO of Arete Therapeutics
  • 2010 Global Head and Vice President of Genentech Partnering
  • 2013 Global Head and Senior Vice President of Genentech Partnering
  • 2018 Global Head of Roche Pharma Partnering and Member of the Roche Enlarged Corporate Executive Committee (to present)
  • 2019 Director of the Company (to present)

Audit & Supervisory Board Members

Photo:Atsushi Sato Atsushi Sato Audit & Supervisory Board Member (full-time)

Date of Birth    February 10, 1959

  • 1981 Joined the Company
  • 2009 Head of Risk Management & Compliance Dept.
  • 2011 Head of Corporate Social Responsibility Dept.
  • 2015 Head of Corporate Social Responsibility Dept. and General Affairs Dept.
    Head of Corporate Social Responsibility Dept.
  • 2016 Associate Vice President, Head of Corporate Social Responsibility Dept.
  • 2019 Associate Vice President
    Audit & Supervisory Board Member (to present)
Photo:Dr. Yoshiaki Ohashi Dr. Yoshiaki Ohashi Audit & Supervisory Board Member (full-time)

Date of Birth    January 8, 1960

  • 1988 Joined the Company
  • 2004 Department Manager, Quality & Regulatory Compliance Dept.
  • 2009 Department Manager, Drug Safety Coordination Dept.
  • 2011 Global PV Head, Pharmacovigilance Manager
  • 2013 Head of Drug Safety Div. and Department Manager of Drug Safety Coordination Dept.
  • 2015 Vice President, Head of Drug Safety Div.
    Vice President, Head of Quality & Regulatory Compliance Unit, and Head of Drug Safety Div.
  • 2018 Senior Vice President, Head of Quality & Regulatory Compliance Unit and Head of Drug Safety Div.
  • 2021 Senior Vice President
    Audit & Supervisory Board Member (to present)
Photo:Takaaki Nimura OutsideIndependent Takaaki NimuraRepresentative of Nimura Certified Public Accountant Office

Date of Birth    October 25, 1949

  • 1974 Joined Arthur Young & Co., Tokyo Office
  • 1980 Seconded to Asahi & Co., Osaka Office
  • 1983 Seconded to Arthur Young & Co., Los Angeles Office
  • 1989 Partner, Asahi Shinwa & Co.
  • 1993 Joined Showa Ota & Co.
  • 1997 Senior Partner, Showa Ota & Co.
  • 2008 Executive Board Member, Ernst & Young ShinNihon LLC
  • 2010 Established Nimura Certified Public Accountant Office
  • 2012 Outside Director, Sony Corporation
  • 2016 Outside Audit & Supervisory Board Member of the Company (to present)
Photo:Dr. Yuko Maeda OutsideIndependent Dr. Yuko MaedaDirector, CellBank Corp.
External Director, Kosé Corporation
Auditor (part-time), Japan Agency for Marine-Earth Science and Technology
Executive Vice President (part-time), Kyushu University

Date of Birth    July 26, 1960

  • 1984 Joined Bridgestone Corporation
  • 1998 CFO of BTR Power Systems Japan
  • 2001 Vice President of Tokyo University of Agriculture and Technology TLO Co., Ltd.
  • 2003 Director, Technology Transfer Center of Tokyo Medical and Dental University
  • 2009 Project Coordinator of Innovation Initiative Network Japan
    Visiting Professor of Tokyo Medical and Dental University
  • 2011 Specially Appointed Professor of Kyoto Prefectural University of Medicine
  • 2013 Executive Officer of Bridgestone Corporation
  • 2014 Auditor (part-time) of Japan Agency for Marine-Earth Science and Technology (to present)
  • 2017 Director of CellBank Corp. (to present)
  • 2019 Outside Audit & Supervisory Board Member of the Company (to present)
  • 2020 External Director, Kosé Corporation (to present)
    Executive Vice President, Kyushu University (part-time)
Photo:Kenichi Masuda OutsideIndependent Kenichi Masuda Partner of Anderson Mōri & Tomotsune
Outside Director of Bridgestone Corporation
Outside Corporate Auditor of LIFENET INSURANCE COMPANY
Outside Audit & Supervisory Board Member of Mercuria Investment Co.,Ltd.
Visiting Professor of School of Law, The University of Tokyo

Date of Birth    January 11, 1963

  • 1988 Registered as an attorney-at-law (Daini Tokyo Bar Association)
    Joined Anderson Mōri & Tomotsune
  • 1993 Registered as an attorney-at-law in the state of New York
  • 1997 Partner of Anderson Mōri & Tomotsune (to present)
  • 2007 Outside Corporate Auditor of LIFENET INSURANCE COMPANY (to present)
  • 2010 Part-time Lecturer at School of Law, The University of Tokyo
  • 2011 Outside Corporate Auditor of Bridgestone Corporation
  • 2016 Outside Director of Bridgestone Corporation (to present)
  •   Outside Audit & Supervisory Board Member of Mercuria Investment Co., Ltd. (to present)
  • 2019 Visiting Professor of School of Law, The University of Tokyo (to present)
  • 2020 Outside Audit & Supervisory Board Member of the Company (to present)

Executive Officers

Tetsuya Yamaguchi
Executive Vice President
Supervisory responsibility for Project & Lifecycle Management (Marketing), Drug Safety, Medical Affairs and Foundation Medicine
Head of Project & Lifecycle Management Unit
Junichi Ebihara
Executive Vice President
Supervisory responsibility for Legal, Intellectual Property, General Affairs, Risk Management, Compliance and Quality & Regulatory Compliance
In charge of Legal Dept., Intellectual Property Dept., and General Affairs Dept.
Shinji Hidaka
Executive Vice President
Supervisory responsibility for Marketing & Sales
Head of Marketing & Sales Div.
Yoshiyuki Yano
Executive Vice President
Supervisory responsibility for Human Resource Management and EHS
Head of Human Resources Management Dept.
In charge of Sustainability Dept.
Satoko Shisai
Executive Vice President
Supervisory responsibility for Digital Transformation
Head of Digital Transformation Unit
Mark Noguchi
Senior Vice President
Head of Partnering Dept.
Dr. Minoru Watanabe
Vice President
Head of Drug Safety Div and Head of Foundation Medicine Unit
Dr. Junichi Nezu
Vice President
Head of R&D Portfolio Management Dept. of Project & Lifecycle Management Unit
Tsukasa Kusano
Vice President
Head of Clinical Development Div.
Dr. Kaori Ouchi
Vice President
Head of Medical Affairs Div.
Shinya Takuma
Vice President
Head of Pharmaceutical Technology Div. and Chugai Pharma Manufacturing Co., Ltd. (President)
Dr. Hitoshi Iikura
Vice President
Head of Research Div.
Masayoshi Higuchi
Vice President
Head of Quality & Regulatory Compliance Unit
  • Like
  • Tweet
  • LINE it!
  • E-mail

Company Outline

Back to top